Loading…
Kimia Biosciences (BSE 530313)₹30.08−0.07%Pharmaceuticals
At the end of the Jun 2026 quarter, Kimia Biosciences' shareholders were: promoters 74.97%, DIIs 0.38%, public 24.65%. Promoter holding is unchanged on the quarter. 0.00% of promoter shares were pledged. It had 12,774 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 74.97% | 74.97% | 74.97% | 74.97% | 74.97% | 74.97% | 74.97% | 74.97% | 74.97% | 74.97% | 74.97% | 74.97% |
| DIIs | 0.38% | 0.38% | 0.38% | 0.38% | 0.38% | 0.38% | 0.38% | 0.38% | 0.38% | 0.38% | 0.38% | 0.38% |
| Public | 24.65% | 24.65% | 24.65% | 24.65% | 24.65% | 24.65% | 24.65% | 24.65% | 24.65% | 24.65% | 24.65% | 24.65% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 12,117 | 12,062 | 12,109 | 12,022 | 12,178 | 12,230 | 12,277 | 12,199 | 12,615 | 12,750 | 12,774 | 12,774 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Sameer Goel | Promoter | 74.92% | 0.00 |
| Anish Kumar Aggarwal | Public | 4.31% | 0.00 |
| Manish Gupta | Public | 4.22% | 0.00 |
| Roma Mittal | Public | 4.07% | 0.00 |
| Rahul Agrawal | Public | 3.36% | 0.00 |
Promoters held 74.97% of Kimia Biosciences at the end of the Jun 2026 quarter, the same as a year earlier.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held no reported stake and domestic institutions (DIIs) held 0.38% (unchanged at 0.38% a quarter earlier).
No. The Jun 2026 filing shows no pledged promoter shares.
Kimia Biosciences had 12,774 shareholders at the end of the Jun 2026 quarter, against 12,199 a year earlier.
Anish Kumar Aggarwal (Public) held 4.31% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.